Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study

Table 2 Progression of CKD according to the renal function during the study period (N = 503)

Annual progression of CKD	Patient’s condition at the end of the study
N (%)	Without ESRD	ESRD	Death	Total
Improvement of renal function^a	96 (57.8 %)	12 (7.2 %)	58 (35 %)	166
Physiological decline^b	74 (69.8 %)	5 (4.7 %)	27 (25.5 %)	106
Moderate decline^c	48 (52.2 %)	12 (13 %)	32 (34.8 %)	92
Rapid decline^d	39 (28.1 %)	29 (20.9 %)	71 (51.0 %)	139
Total	257	58	188	503

CKD chronic kidney disease, ESRD end-stage renal disease
^aif the difference between the final and initial values of serum creatinine (fSC-iSC) was ≤0
^bif 0 < fSC-iSC ≤ 2
^cif 2 < fSC-iSC < 5
^dif fSC-iSC ≥ 5

ISSN: 1471-2369